Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
658.70
-12.6 (-1.88%)
BSENSE

Oct 09

BSE+NSE Vol: 1.69 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryBliss GVS Pharma VS Pharmaceuticals & Biotechnology
 
1D
-1.88%
1.23%
1W
-3.73%
0.78%
1M
-4.91%
-3.07%
YTD
302.87%
-14.96%
1Y
318.89%
-11.8%
3Y
642.78%
10.62%
5Y
482.92%
20.67%
10Y
348.55%
158.27%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.22%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.78%
0%
25.78%
6 Months
159.02%
0.38%
159.4%
1 Year
318.89%
0.99%
319.88%
2 Years
411.81%
1.51%
413.32%
3 Years
642.78%
3.10%
645.88%
4 Years
770.15%
3.97%
774.12%
5 Years
482.92%
3.34%
486.26%

Latest dividend: 1 per share ex-dividend date: Jul-08-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Bliss GVS Pharma Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-2.75%
2
Quartile
quartile-2
Jun-Sep
28.38%
1
Quartile
quartile-1
Mar-Jun
149.71%
1
Quartile
quartile-1
YTD
327.34%
2
Quartile
quartile-2
2025
-0.7%
3
Quartile
quartile-3
2024
32.14%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Bliss GVS Pharma Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-2.75%
1
Quartile
quartile-1
Jun-Sep
28.38%
1
Quartile
quartile-1
Mar-Jun
149.71%
1
Quartile
quartile-1
YTD
327.34%
1
Quartile
quartile-1
2025
-0.7%
3
Quartile
quartile-3
2024
32.14%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Good Performer

Bliss GVS Pharma Ltd has been in the First and Second Quartile in the YTD and longer periods

2
Quartile
quartile-2
QTD
-2.75%
1
Quartile
quartile-1
Jun-Sep
28.38%
1
Quartile
quartile-1
Mar-Jun
149.71%
1
Quartile
quartile-1
YTD
327.34%
2
Quartile
quartile-2
2025
-0.7%
2
Quartile
quartile-2
2024
32.14%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available